ESC 365 - Efficacy and safety of adding omega-3 fatty acids in statin-treated patients with residual hypertriglyceridemia: a randomized, double-blind, and placebo-controlled trial

ESC Premium Access

Efficacy and safety of adding omega-3 fatty acids in statin-treated patients with residual hypertriglyceridemia: a randomized, double-blind, and placebo-controlled trial

Session: Poster session 7 - Lipids

Topic: Lipids (Epidemiology and Prevention)

Speaker: Doctor C. Kim (Seoul, KR)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Chee Hae Kim

Dongguk University Ilsan Hospital, Seoul (Korea (Republic of))

0 follower

14 more presentations in this session

Impact of the european and american guidelines on the management and treatment of dyslipidemia in a spanish working population

Speaker: Doctor C. Brotons (Barcelona, ES)

Management of hypercholesterolaemia in non-Western countries and achievement of LDL-C goals: an international, cross-sectional, observational study

Speaker: Professor N. Danchin (Paris, FR)

Lipid goals are poorly attained in majority of patients with familial hypercholesterolemia in Latvia at the time of inclusion in the national registry

Speaker: Professor G. Latkovskis (Riga, LV)

The metabolism of triglyceride-rich lipoproteins is impaired in patients with obstructive sleep apnoea: effects of treatment with continuous positive airway pressure.

Speaker: Associate Professor L. Drager (Sao Paulo, BR)

Clinical characteristics and cardiovascular outcomes in subjects who developed acute myocardial infarction despite statin therapy.

Speaker: Doctor K. Tsuda (Takatsuki, JP)

Access the full session

Poster session 7 - Lipids

Speakers: Doctor C. Kim, Doctor C. Brotons, Professor N. Danchin, Professor G. Latkovskis, Associate Professor L. Drager...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources